Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 48 (1995), S. 109-114 
    ISSN: 1432-1041
    Keywords: Congestive heart ailure ; Molsidomine ; haemodynamics ; sustained released formulation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Abstract We investigated the extent and duration of the haemodynamic effects of two regimens of molsidomine, i.e. two tablets of a standard regimen consisting of 4 mg given 6 h apart and one tablet of 16 mg in sustained-release form once daily in 13 patients with chronic congestive heart failure using a placebo-controlled, randomized, double-blind and crossover protocol over a period of 12 h. Both regimens significantly affected systolic, mean and diastolic pulmonary arterial pressure (reductions of up to 15%), right atrial pressure (reductions of up to 35%) and total pulmonary resistance (reductions of up to 18%). The lower dose achieved its maximum action after about 1 h and remained effective for 2 h, whereas the higher dose in sustained-release form showed maximal efficacy at 2 h and remained active even at 12 h. In contrast, only minor changes in arterial blood pressure, systemic vascular resistance and cardiac output were observed on both regimens, almost exclusively at 2 h. Heart rate was not affected by either of the regimens tested. Neither regimen led to any untoward adverse effects. Thus, molsidomine is a potent vasodilating agent which, apart from its effects on preload, also acts on pulmonary arterial and right atrial pressures, leaving systemic circulation largely unaffected on the regimens tested. Administered on its own, it is therefore suitable for treatment of congestive heart failure.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Der Internist 38 (1997), S. 448-452 
    ISSN: 1432-1289
    Keywords: Schlüsselwörter Stickstoffmonoxid ; NO ; NO-Donoren ; Nitrate ; NO ; Herzinsuffizienz ; Therapie ; Herzinsuffizienz ; Nitrate
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Zum Thema Diese Arbeit beschäftigt sich mit den Stickstoffmonoxid (NO)-Donoren in der Therapie der chronischen Herzinsuffizienz. Dazu werden zunächst die pathophysiologischen Grundlagen für den wirksamen Einsatz von NO-Donoren erläutert. NO-Donoren sind die Substanz Molsidomin und 3 organische Nitratverbindungen: Glyzerolnitrat (GTN), Isosorbiddinitrat (ISDN) und Isosorbid-5-Mononitrat (IS-5-MN). Im Vergleich zum gesunden Probanden weist das NO-System beim herzinsuffizienten Patienten Besonderheiten auf, die für den Einsatz von NO-Donoren zu berücksichtigen sind. Das NO-System ist im kardialen Bereich besonders intensiv untersucht, obwohl es nicht einmal 2 Dekaden als solches bekannt ist. Für die Wirkweise der Nitrate, die schon seit mehr als 40 Jahren bei der Herzinsuffizienz angewendet werden, liefert das NO-System wesentliche Erklärungen und trägt auch zum Verständnis der Pathophysiologie der Herzinsuffizienz erheblich bei.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 0044-2313
    Keywords: Magnesium compound ; phthalocyanine complex ; crystal structure ; vibrational spectra ; Chemistry ; Inorganic Chemistry
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology
    Description / Table of Contents: Magnesium Phthalocyanines: Synthesis and Properties of Halophthalocyaninatomagnesate, [Mg(X)Pc2-]- (X = F, Cl, Br); Crystal Structure of Bis(triphenylphosphine)iminiumchloro-(phthalocyaninato)magnesate Acetone SolvateMagnesium phthalocyanine reacts with excess tetra(n-butyl)ammonium- or bis(triphenylphosphine)iminiumhalide ((nBu4N)X or (PNP)X; X = F, Cl, Br) yielding halophthalocyaninatomagnesate ([Mg(X)Pc2-]-; X = F, Cl, Br), which crystallizes in part as a scarcely soluble (nBu4N) or (PNP) complex-salt. Single-crystal X-ray diffraction analysis of b(PNP)[Mg(Cl)Pc2-] · CH3COCH3 reveals that the Mg atom has a tetragonal pyramidal coordination geometry with the Mg atom displaced out of the center (Ct) of the inner nitrogen atoms (Niso) of the nonplanar Pc ligand toward the Cl atom (d(Mg—Ct) = 0.572(3) Å; d(Mg—Cl) = 2.367(2) Å). The average Mg—Niso distance is 2.058 Å. Pairs of partially overlapping anions are present. The cation adopts a bent conformation (b(PNP)+: d(P1—N(K)) = 1.568(3) Å; d(P2—N(K)) = 1.587(3) Å; ∡(P1—N(K)—P2) = 141.3(2)°). Electrochemical and spectroscopic properties are discussed.
    Notes: Magnesiumphthalocyanin reagiert mit überschüssigem Tetra(n-butyl)ammonium- oder Bis(triphenylphosphin)iminiumhalogenid ((nBu4N)X oder (PNP)X; X = F, Cl, Br) zu Halogenophthalocyaninatomagnesat ([Mg(X)Pc2-]-; X = F, Cl, Br), welches teilweise als wenig lösliches (nBu4N)- oder (PNP)-Komplexsalz kristallisiert. Die Kristallstrukturanalyse von b(PNP)[Mg(Cl)Pc2-] · CH3COCH3 bestätigt die tetragonal-pyramidale Koordinationsgeometrie des Mg-Atoms, wobei dieses aus dem Zentrum (Ct) der inneren vier Stickstoffatome (Niso) des nicht-planaren Pc-Liganden in Richtung des Cl Atoms verschoben ist (d(Mg—Ct) = 0,572(3) Å; d(Mg—Cl) = 2,367(2) Å). Der mittlere Mg—Niso-Bindungsabstand beträgt 2,058 Å. Im festen Zustand bilden je zwei Anionen partiell überlappende Dimere. Das Kation liegt in gewinkelter Konformation vor (b(PNP)+: d(P1—N(K)) = 1,568(3) Å; d(P2—N(K)) = 1,587(3) Å; ∡(P1—N(K)—P2) = 141,3(2)°). Elektrochemische und spektroskopische Eigenschaften werden diskutiert.
    Additional Material: 6 Ill.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...